TITLE:
A Study of Intravenous or Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients

CONDITION:
Anemia

INTERVENTION:
epoetin alfa or beta

SUMMARY:

      This study will assess the efficacy and safety of intravenous (iv) or subcutaneous (sc)
      Mircera, administered with pre-filled syringes, as maintenance treatment for renal anemia in
      chronic kidney disease patients on dialysis who were previously receiving iv or sc epoetin.
      The anticipated time on study treatment is 3-12 months and the target sample size is 100-500
      individuals.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  adult patients >=18 years of age;

          -  chronic renal anemia;

          -  on dialysis therapy for at least 12 weeks before screening;

          -  receiving iv or sc epoetin for at least 8 weeks before screening.

        Exclusion Criteria:

          -  women who are pregnant, breastfeeding or using unreliable birth control methods;

          -  administration of another investigational drug within 4 weeks before screening, or
             during the study period.
      
